Efficacy and safety of alirocumab in Korean patients with hypercholesterolemia and high cardiovascular risk: subanalysis of the ODYSSEY-KT study.

CW, Nam; DS, Kim; J, Li; MT, Baccara-Dinet; I, Li; JH, Kim; CJ, Kim

doi:10.3904/kjim.2018.133

Public

Efficacy and safety of alirocumab in Korean patients with hypercholesterolemia and high cardiovascular risk: subanalysis of the ODYSSEY-KT study.

Shared by NobleBlocks on Sep 1, 2018 • 12:00 AM UTC

Authors:

Nam CW

Kim DS

Li J

Abstract

<h4>Background/aims</h4>Efficacy and safety data of alirocumab, a fully human monoclonal antibody to proprotein convertase subtilisin/kexin type 9 (PCSK9), is not yet well established in the Korean population. We assessed them in ODYSSEY-KT through the pre-specified Korean subanalysis.<h4>Methods</h...

Subject

Hypercholesterolemia

Cholesterol

Ldl

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!